EUA NG MODERNA VACCINE APRUBADO NA NG FDA

Ni Monica N. Ladisla
Source: PTV News
Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

Inaprubahan na ng Food and Drug Administration ang emergency use authorization (EUA) ng bakunang gawa ng Moderna.

Maaaring ipamahagi at gamitin sa vaccination program ng gobyerno ang bakunang mayroong EUA mula sa FDA.

“After rigorous and thorough review by regulatory and medical experts using the currently available published and unpublished data, FDA is granting an emergency use authorization… for the COVID-19 vaccine Moderna,” ulat ni FDA Director General Eric Domingo.

Umabot lamang umano ng sampung araw bago opisyal na nabigyan ng EUA ang naturang bakuna.

Inaasahang darating na sa Hunyo ang 200,000 doses ng bakunang binili ng gobyerno mula sa Moderna.

Kamakailan, pumirma rin ng tripartite agreement ang gobyerno at pribadong sektor sa Moderna upang makakuha ng 20 milyong doses ng bakuna.

Sa kasalukuyan, pito na ang vaccine manufacturers na nabigyan ng EUA ng bansa kabilang na ang Pfizer-BioNTech, AstraZeneca, Sinovac Biotech, Gamaleya Institute, Janssen, at Bharat Biotech.

CONTACT US

Anchored on its mantra, “Sentro ng Katotohanan, Tapat sa Mamamayan”, Balita Central Digital complements and supports the Balita Central newspaper published bi-monthly to combat fake news and to provide the public with easy-to-digest news bits that are sourced solely from the Presidency and government agencies. 

Balita Central is under the supervision of the Bureau of Communications Services (BCS), one of the attached agencies of the Presidential Communications Operations Office (PCOO).

Launched on February 28, 2019 at the Manila Light Rail Transit System Line 2 (LRT-2) Cubao Station, Quezon City, it also aims to raise awareness among local communities about the policies, programs, and accomplishments of the Presidency. 

Through this platform, Balita Central Digital aims to reach further the online community to deliver more accurate information and communication services in order to educate the citizenry regarding national issues which would enlighten them to be engaged and be empowered in contributing to building a better nation.

Balita Central is situated at the BCS Headquarters located beside the Philippine Cancer Society along San Rafael, San Miguel, Malacañang Complex, Manila City. Its official website address is balitacentral.ph.

For inquiries and feedback, Balita Central may be contacted at editorialdesk.bcs@gmail.com.